A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
Public ClinicalTrials.gov record NCT03559257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and efficacy of galcanezumab in people with treatment-resistant episodic or chronic migraine.
Study identification
- NCT ID
- NCT03559257
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 463 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2018 (Actual)
- Primary completion
- Jun 19, 2019 (Actual)
- Completion
- Sep 19, 2019 (Actual)
- Last update posted
- Jul 8, 2020
2018 – 2019
United States locations
- U.S. sites
- 18
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 21st Century Neurology | Phoenix | Arizona | 85004 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| Sensible Healthcare | Ocoee | Florida | 34761 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Renstar Medical Research | Wesley Chapel | Florida | 33544 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| Michigan Head, Pain and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Clinical Research Institute | Minneapolis | Minnesota | 55402 | — |
| Healthy Perspectives Innovative Mental Health Services, PL | Nashua | New Hampshire | 03060 | — |
| Bio Behavioral Health | Toms River | New Jersey | 08755 | — |
| Albuquerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| PharmQuest | Greensboro | North Carolina | 27408 | — |
| Lehigh Center for Clinical Research | Allentown | Pennsylvania | 18104 | — |
| Coastal Carolina Research Center, Inc. | Mt. Pleasant | South Carolina | 29464 | — |
| Foothill Family Clinic | Salt Lake City | Utah | 84109 | — |
| Health Research of Hampton Roads Inc | Newport News | Virginia | 23606 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007-4209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03559257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03559257 live on ClinicalTrials.gov.